Tag: Radical Catheter Technologies
Radical gains US FDA 510(k) clearance for 6F neurovascular access catheter
Radical Catheter Technologies—a NeuroTechnology Investors (NTI) portfolio company—announced today that the US Food and Drug Administration (FDA) has granted 510(k) clearance to its 6F...
Serenity gains “landmark” US FDA humanitarian device exemption for novel cerebral...
Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company, has today announced a “landmark” US Food and Drug Administration (FDA) humanitarian device exemption (HDE) approval for its novel...
Radical gains US FDA 510(k) clearance for 8Fr neurovascular catheter
Radical Catheter Technologies, a NeuroTechnology Investors (NTI) portfolio company, has announced the Food and Drug Administration (FDA) clearance of its 8Fr neurovascular catheter, marking...
Radical presents initial data on recently US FDA-cleared catheter technology at...
Radical Catheter Technologies has announced 510(k) clearance by the US Food and Drug Administration (FDA) for its Radical catheter—which, the company claims in a...
